125 related articles for article (PubMed ID: 10639589)
1. Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract.
Hiratou T; Miyano-Kurosaki N; Tsukahara S; Tamura Y; Takai K; Yamamoto N; Takaku H
Int J Mol Med; 2000 Feb; 5(2):125-32. PubMed ID: 10639589
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Yamamoto N; Takaku H
FEBS Lett; 1999 Jul; 456(1):186-90. PubMed ID: 10452555
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 activity by a triple-helix forming oligonucleotides targeted to polypurine tract on viral RNA.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Saito T; Yamamoto N; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1721-34. PubMed ID: 11200268
[TBL] [Abstract][Full Text] [Related]
4. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
Hiratou T; Tsukahara S; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1997; (37):221-2. PubMed ID: 9586079
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
[TBL] [Abstract][Full Text] [Related]
7. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
[TBL] [Abstract][Full Text] [Related]
8. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
9. Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cells.
El Dirani-Diab R; Sarih-Cottin L; Delord B; Dumon B; Moreau S; Toulme JJ; Fleury H; Litvak S
Antimicrob Agents Chemother; 1997 Oct; 41(10):2141-8. PubMed ID: 9333039
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A.
Jendis J; Strack B; Moelling K
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):999-1005. PubMed ID: 9686646
[TBL] [Abstract][Full Text] [Related]
12. The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.
Volkmann S; Dannull J; Moelling K
Biochimie; 1993; 75(1-2):71-8. PubMed ID: 7684936
[TBL] [Abstract][Full Text] [Related]
13. Single strand targeted triplex-formation. Destabilization of guanine quadruplex structures by foldback triplex-forming oligonucleotides.
Kandimalla ER; Agrawal S
Nucleic Acids Res; 1995 Mar; 23(6):1068-74. PubMed ID: 7537368
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA.
Volkmann S; Jendis J; Frauendorf A; Moelling K
Nucleic Acids Res; 1995 Apr; 23(7):1204-12. PubMed ID: 7537875
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
Lund OS; Nielsen JO; Hansen JE
Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
17. Glucose conjugation of anti-HIV-1 oligonucleotides containing unmethylated CpG motifs reduces their immunostimulatory activity.
Reyes-Darias JA; Sánchez-Luque FJ; Morales JC; Pérez-Rentero S; Eritja R; Berzal-Herranz A
Chembiochem; 2015 Mar; 16(4):584-91. PubMed ID: 25683851
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
[TBL] [Abstract][Full Text] [Related]
19. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
Zelphati O; Zon G; Leserman L
Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
